Karyopharm Therapeutics Inc. Q4 Loss misses estimates

(RTTNews) - Karyopharm Therapeutics Inc. (KPTI) reported Loss for fourth quarter that missed the Street estimates.

The company's bottom line came in at -$41.837 million, or -$0.36 per share. This compares with -$38.506 million, or -$0.43 per share, in last year's fourth quarter.

Analysts on average had expected the company to earn -$0.31 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 0.5% to $33.747 million from $33.580 million last year.

Karyopharm Therapeutics Inc. earnings at a glance (GAAP) :

-Earnings (Q4): -$41.837 Mln. vs. -$38.506 Mln. last year. -EPS (Q4): -$0.36 vs. -$0.43 last year. -Revenue (Q4): $33.747 Mln vs. $33.580 Mln last year.